[1] |
Ren Yufei, Chen Xiaoqing, Kong Weizong, et al..
Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro
[J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
|
[2] |
Li Yingyi, Guo Cuifen, Zhang Ruinan, et al..
Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease
[J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
|
[3] |
Zhang Lanhua, Shao Qin, Xia Zhenjuan.
Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
|
[4] |
Huo Huiqin, Gong Xiaohong, Li Zhenghong.
Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.
|
[5] |
Xie Xiao, Lu Lungen.
Noninvasive diagnosis and assessment of patients with nonalcoholic steatohepatitis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 301-306.
|
[6] |
Zhong Yan, Su Shuting, Mi Yuqiang..
Treatment of patients with nonalcoholic fatty liver disease
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
|
[7] |
Huang Jiaofeng, Lin Su, Wang Mingfang, et al..
Impact of entecavir therapy on hepatic steatosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 863-867.
|
[8] |
Huang Faguang, Li Xiaocheng, Gong Jianping, et al..
Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
|
[9] |
Pu Yonglan, Chen Yuanwen, Fan Jiangao..
Gluten intestinal disease and nonalcoholic fatty liver: One case report
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
|
[10] |
Yan Chenli, Wang Jingjing, Wang Jun..
Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
|
[11] |
Bing Hao, Li Yiling..
Correlation between non-alcoholic fatty liver disease and hepatocellular carcinoma:Fact or fiction
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 821-824.
|
[12] |
Wang Xinwei, Lyu Ke, Sun Xiao, et al.
Effect of selective β3-adrenergic receptor agonist on hepatic oxidative stress and liver fibrosis in rats with nonalcoholic fatty liver disease
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 384-387.
|
[13] |
Li Caihong, Lian Lingling, Lu Derong.
Preliminary trial of ezetimibe combined with atorvastatin in treatment of patient with nonalcoholic fatty liver disease complicated by coronary heart disease
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 405-408.
|
[14] |
He Xiaoping, Ran Dongmei, Qing Ling.
Improved compliance of life style in patients with nonalcoholic fatty liver disease by family visit based on cross-theretical model of change
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 465-466.
|
[15] |
Zeng Minde.
Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.
|